Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.03
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
2.20
Today|||52-Week Range
4.07
-14.41%
Year-to-Date
Celldex Begins Phase I Trial on Cancer Candidate CDX-1140
Dec 01 / Zacks.com - Paid Partner Content
Cancer Space Update: Pfizer's Bavencio Fails in Phase III
Dec 01 / Zacks.com - Paid Partner Content